RNA Competitors & Alternatives
Compare Atrium Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
RNA
Main Stock$12.22
Tradestie Score
53
Market Cap
$6.27B
Revenue Growth
11.5%
Analyst Upside
+104.6%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.03
|
$269.08M | - | 59 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$7.77
|
$258.18M | - | 46 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$38.32
|
$256.54M | - | 62 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$12.62
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.50
|
$202.58M | - | 63 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$26.96
|
$188.81M | 342.5 | 55 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$44.12
|
$180.53M | - | 62 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.91
|
$170.45M | - | 58 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.10
|
$158.43M | - | 57 | Compare |
More RNA Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry